SCHEMBL9915312

SCHEMBL9915312

CCCCOc1cnc(CN2C(=O)c3ccccc3C2=O)cc1OCCCC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
PKM P14618 1/20 0.47
MAPT P10636 4/20 0.45
RECQL P46063 1/20 0.45
HPGD P15428 4/20 0.43
TSHR P16473 4/20 0.43
RAB9A P51151 4/20 0.43
NPC1 O15118 1/20 0.43
L3MBTL1 Q9Y468 2/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 2/20 0.41
PTK2B Q14289 1/20 0.40
ALOX15 P16050 1/20 0.40
ALOX12 P18054 1/20 0.40
HSD17B10 Q99714 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
TP53 P04637 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14124890 0.81 KMT2A (0.48) ALDH1A1KMT2AMEN1PKMMAPT
SCHEMBL15319662 0.80 CASP3 (0.54) KMT2AMEN1RAB9A
SCHEMBL15351771 0.75 HPGD (0.46) ALDH1A1KMT2AMEN1PKMMAPT
SCHEMBL9915307 0.74 RAB9A (0.43) ALDH1A1KMT2AMEN1MAPTHPGD
SCHEMBL15279029 0.74 KMT2A (0.41) ALDH1A1KMT2AMAPTHPGDTSHR
SCHEMBL15923220 0.72 MAPT (0.62) ALDH1A1KMT2AMEN1MAPTRECQL
SCHEMBL30036364 0.72 KMT2A (0.46) KMT2AMAPTHPGDTSHRRAB9A
SCHEMBL3578423 0.72 RAB9A (0.52) ALDH1A1KMT2AMEN1PKMMAPT
SCHEMBL15350422 0.72 MAPT (0.45) ALDH1A1KMT2AMEN1PKMMAPT
SCHEMBL15351154 0.72 KMT2A (0.45) ALDH1A1KMT2AMEN1PKMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150148326-A1 Monobactams PFIZER (US) 2015-05-28 US disclosed
EP-2646436-B1 MONOBACTAMS PFIZER (US) 2015-05-27 EP disclosed
US-20130252935-A1 Monobactams PFIZER INC. (US) 2013-09-26 US disclosed
US-20120302542-A1 MONOBACTAMS PFIZER INC 2012-11-29 US disclosed
WO-2012073138-A1 MONOBACTAMS PFIZER INC. (US) 2012-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130252935-A1 Monobactams MGAM, MGAM2, BPGM ALDH1A1 1829/4885KMT2A 608/4885MEN1 2023/4885
US-20150148326-A1 Monobactams MGAM, MGAM2, BPGM ALDH1A1 1829/4885KMT2A 608/4885MEN1 2023/4885
US-20120302542-A1 MONOBACTAMS MGAM, MGAM2, BPGM ALDH1A1 1829/4885KMT2A 608/4885MEN1 2023/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.